Please login to the form below

Not currently logged in
Email:
Password:

Bicycle Therapeutics

This page shows the latest Bicycle Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

Alan Watt has been in drug research for more than 30 years, having worked for Merck &Co, GSK and biotech, Cellzome, Trident Biopharma and Bicycle Therapeutics before setting up NodThera.

Latest news

  • AstraZeneca expands alliance with Bicycle Therapeutics AstraZeneca expands alliance with Bicycle Therapeutics

    Collaboration to seek out new respiratory and cardio-metabolic drugs. AstraZeneca must be pleased with its $1bn alliance with Bicycle Therapeutics to seek out new respiratory and cardio-metabolic drugs, as ... The company’s cancer portfolio is

  • AZ signs $1bn deal with Bicycle Therapeutics AZ signs $1bn deal with Bicycle Therapeutics

    Eyes broad range of applications for the firm’s peptide technology.  . UK start-up Bicycle Therapeutics has attracted big pharma interest in its bicyclic peptide technology, signing a wide-ranging deal ... Cambridge-based Bicycle's in-house programmes

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    The in-partnering deals included the $1bn deal with Bicycle Therapeutics and the Alzheimer's collaboration with Lilly. ... But ultimately deals will continue in a diverse range of therapeutic entities as technological improvements appear to be bearing

  • Deal Watch December 2016 Deal Watch December 2016

    and Bicycle Therapeutics at $1bn, and the Purdue Pharma-Exicure deal, at $790m. ... The size of the deals signed by AstraZeneca with Bicycle Therapeutics, by Spark with Selecta Biosciences and by Celgene with Evotec suggest that their technologies

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Bicycle Therapeutics appoints former Pfizer VP Maria Koehler Bicycle Therapeutics appoints former Pfizer VP Maria Koehler

    She joins the UK biotech as its chief medical officer. Bicycle Therapeutics has appointed Maria Koehler as its chief medical officer, a role that will see her lead clinical strategy and ... Dr Kevin Lee, chief executive officer at  Bicycle Therapeutics,

  • Bicycle Therapeutics appoints Lee Kalowski Bicycle Therapeutics appoints Lee Kalowski

    He joins the biotech from Tokai Pharmaceuticals. Biotechnology group Bicycle Therapeutics has appointed Lee Kalowski as chief financial officer at a time when the company explores a new class of therapeutics ... Kevin Lee, chief executive officer of

  • Dr Stephen Hoffman joins Bicycle Therapeutics Dr Stephen Hoffman joins Bicycle Therapeutics

    He becomes chairman of the board. Cambridge, UK-headquartered Bicycle Therapeutics has named Dr Stephen Hoffman as chairman of its board of directors. ... Kevin Lee, chief executive of Bicycle Therapeutics, said: “Stephen has significant global

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics